Triple therapy reduced mortality more than oseltamivir alone in patients admitted for severe influenza infection
Ann Intern Med
.
2017 Oct 17;167(8):JC41.
doi: 10.7326/ACPJC-2017-167-8-041.
Authors
Nikolaos Andreatos
,
Eleftherios Mylonakis
PMID:
29049760
DOI:
10.7326/ACPJC-2017-167-8-041
No abstract available
Publication types
Comment
MeSH terms
Antiviral Agents
Hospitalization
Humans
Influenza A Virus, H1N1 Subtype
Influenza, Human*
Oseltamivir*
Substances
Antiviral Agents
Oseltamivir